Vaccine News and Research

Latest Vaccine News and Research

Maternal smoking during pregnancy associated with twofold increased risk of BD in offspring

A study published today in the American Journal of Psychiatry suggests an association between smoking during pregnancy and increased risk for developing bipolar disorder in adult children.

2 Oct 2013

Merck & Co. Axes 8,500 In R&D Restructuring

...

1 Oct 2013

Merck & Co. Axes 8,500 In R&D Restructuring

...

1 Oct 2013

Canada should start screening 'Baby Boomers' for hepatitis C virus infection, say liver specialists

Canada should begin screening 'Baby Boomers' for the hepatitis C virus infection, since this age group is likely the largest group to have the illness, and most don't know they have it, say a group of liver specialists in the Toronto Western Hospital Francis Family Liver Clinic. Unlike many other chronic viral infections, early treatment makes hepatitis C curable.

1 Oct 2013

Three UC Irvine scientists receive prestigious 2013 NIH New Innovator Awards

UC Irvine scientists Aaron Esser-Kahn, Sunil Gandhi and Ali Mortazavi have been named recipients of the prestigious 2013 National Institutes of Health Director's New Innovator Awards.

1 Oct 2013

Diabetes puts you at increased risk of flu-related complications

There are certain groups of people who are at risk of serious flu complications each year, including those with diabetes.

30 Sep 2013

FDA expands Hizentra administration options for people with primary immunodeficiency

CSL Behring announced today that the U.S. Food and Drug Administration has expanded the administration options for Hizentra, Immune Globulin Subcutaneous (Human), 20% Liquid, to include dosing once every two weeks (biweekly) for people diagnosed with primary immunodeficiency.

28 Sep 2013

SBIR Awards Etubics $1.5M To Manufacture Breast Cancer Immunotherapy

...

27 Sep 2013

University of Maryland receives renewed NIH funding for vaccine research

The University of Maryland School of Medicine's Center for Vaccine Development (CVD) has successfully competed for and received a renewed contract to conduct basic research and clinical studies of vaccines, diagnostics, and therapeutics. Support for this work to combat existing and emerging infectious diseases is provided by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).

27 Sep 2013

HOOKVAC consortium awarded grant to develop, test vaccine for human hookworm

The HOOKVAC consortium, led by the Academic Medical Center at the University of Amsterdam, today announced it has been awarded a grant of six million Euros from the European Commission FP7 programme to expand the Sabin Vaccine Institute Product Development Partnership’s (Sabin PDP) work to develop and test a vaccine for human hookworm, a disease that infects 600-700 million of the world’s poorest people.

27 Sep 2013

VVRP receives contract from NIH to continue its work as Vaccine and Treatment Evaluation Units

The Vanderbilt Vaccine Research Program (VVRP) has received a contract from the National Institutes of Health (NIH) to continue its work as one of the nation's Vaccine and Treatment Evaluation Units (VTEU).

27 Sep 2013

Group Health helps protect public from infectious diseases through nationwide network

A nationwide group of institutions that conducts clinical trials of promising candidate vaccines and therapies for infectious diseases, known as the Vaccine and Treatment Evaluation Units (VTEUs), has been awarded nine contracts to strengthen and broaden the scope of its research. Group Health Research Institute is one of these institutions.

27 Sep 2013

NIH program provides $22M for low- and middle-income countries to combat HIV/AIDS epidemic

A new NIH program supporting HIV-related research training will provide $22 million over five years for activities in 15 low- and middle-income countries. The Fogarty International Center's HIV Research Training Program is issuing 22 awards, which are intended to strengthen the ability of the grantee institutions to combat the HIV/AIDS epidemic, while building expertise in a particular scientific or critical research infrastructure area.

27 Sep 2013

HOOKVAC consortium to begin first clinical testing of human hookworm vaccine in West Africa

The HOOKVAC consortium, led by the Academic Medical Center (AMC) at the University of Amsterdam, today announced it has been awarded a grant of six million Euros from the European Commission FP7 programme to expand the Sabin Vaccine Institute Product Development Partnership's (Sabin PDP) work to develop and test a vaccine for human hookworm, a disease that infects 600-700 million of the world's poorest people.

27 Sep 2013

New public resource to help researchers explore data from the NIH human microbiome project

The National Institutes of Health (NIH) has launched the first phase of the Microbiome Cloud Project (MCP), a collaboration with Amazon Web Services that aims to improve access to and analysis of data from the Human Microbiome Project (HMP).

27 Sep 2013

Pittcon to exhibit at BioConference Live’s “Cancer: Research, Discovery and Therapeutics” online-only event

Pittcon is pleased to announce it will be exhibiting at the next BioConference Live virtual event. BioConference Live, the largest producer of online-only conferences focused on life sciences, laboratory animal sciences and clinical diagnostics, has announced the upcoming “Cancer: Research, Discovery and Therapeutics” online-only conference.

26 Sep 2013

New line of –30˚C biomedical freezers launched by Panasonic

Panasonic has launched a brand new line of -30˚C Biomedical freezers that provide cost-efficient and secure sample storage across a wide range of applications. A combination of technological advances in Panasonic’s new -30˚C freezers reduces energy consumption and improves temperature stability, delivering the effective, reliable environmental control needed when storing valuable materials such as vaccines, diagnostic samples, enzymes, culture media and reagents.

From PHC Europe B.V. 26 Sep 2013

Results of NovaRx's Lucanix Phase III trial in non-small cell lung cancer to be presented at ESMO 2013

NovaRx Corporation announced that the detailed results from the randomized Phase III trial of Lucanix (belagenpumatucel-L) post-frontline maintenance therapy in non-small cell lung cancer will be presented at the European Society for Medical Oncology 2013 annual meeting in Amsterdam.

26 Sep 2013

Ten health care innovations could save lives of mothers and children

Ten health care innovations, if brought to scale immediately in low-resource countries, could have the potential to save the lives of some 1.2 million mothers and children in 2015.

26 Sep 2013

MIT engineers develop nanoparticles that deliver cancer vaccines to lungs

Many viruses and bacteria infect humans through mucosal surfaces, such as those in the lungs, gastrointestinal tract and reproductive tract. To help fight these pathogens, scientists are working on vaccines that can establish a front line of defense at mucosal surfaces.

26 Sep 2013

Vaccine News and Research

Latest Vaccine News and Research

Maternal smoking during pregnancy associated with twofold increased risk of BD in offspring

Merck & Co. Axes 8,500 In R&D Restructuring

Merck & Co. Axes 8,500 In R&D Restructuring

Canada should start screening 'Baby Boomers' for hepatitis C virus infection, say liver specialists

Three UC Irvine scientists receive prestigious 2013 NIH New Innovator Awards

Diabetes puts you at increased risk of flu-related complications

FDA expands Hizentra administration options for people with primary immunodeficiency

SBIR Awards Etubics $1.5M To Manufacture Breast Cancer Immunotherapy

University of Maryland receives renewed NIH funding for vaccine research

HOOKVAC consortium awarded grant to develop, test vaccine for human hookworm

VVRP receives contract from NIH to continue its work as Vaccine and Treatment Evaluation Units

Group Health helps protect public from infectious diseases through nationwide network

NIH program provides $22M for low- and middle-income countries to combat HIV/AIDS epidemic

HOOKVAC consortium to begin first clinical testing of human hookworm vaccine in West Africa

New public resource to help researchers explore data from the NIH human microbiome project

Pittcon to exhibit at BioConference Live’s “Cancer: Research, Discovery and Therapeutics” online-only event

New line of –30˚C biomedical freezers launched by Panasonic

Results of NovaRx's Lucanix Phase III trial in non-small cell lung cancer to be presented at ESMO 2013

Ten health care innovations could save lives of mothers and children

MIT engineers develop nanoparticles that deliver cancer vaccines to lungs

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Newsletters you may be interested in